NVN Liquidation Inc (NOVNQ)
0.0008
0.00 (0.00%)
USD |
OTCM |
Apr 26, 16:00
NVN Liquidation Total Assets (Quarterly): 79.79M for March 31, 2023
Total Assets (Quarterly) Chart
Historical Total Assets (Quarterly) Data
Date | Value |
---|---|
March 31, 2023 | 79.79M |
December 31, 2022 | 90.33M |
September 30, 2022 | 83.27M |
June 30, 2022 | 114.39M |
March 31, 2022 | 112.05M |
December 31, 2021 | 68.96M |
September 30, 2021 | 73.89M |
June 30, 2021 | 79.72M |
March 31, 2021 | 46.98M |
December 31, 2020 | 46.83M |
September 30, 2020 | 46.57M |
June 30, 2020 | 46.86M |
March 31, 2020 | 36.51M |
December 31, 2019 | 29.10M |
September 30, 2019 | 36.72M |
Date | Value |
---|---|
June 30, 2019 | 47.51M |
March 31, 2019 | 21.79M |
December 31, 2018 | 26.36M |
September 30, 2018 | 29.70M |
June 30, 2018 | 38.71M |
March 31, 2018 | 46.30M |
December 31, 2017 | 21.13M |
September 30, 2017 | 29.10M |
June 30, 2017 | 37.46M |
March 31, 2017 | 48.57M |
December 31, 2016 | 52.47M |
September 30, 2016 | 70.43M |
June 30, 2016 | 32.73M |
December 31, 2015 | 49.82M |
Total Assets Definition
Assets are a main portion of the balance sheet of a company that measure things that provide economic value. A few examples of assets of a company include cash, inventories, and accounts receivable. From an accounting perspective, the balance sheet equation is Assets = Liabilities + Shareholder's Equity.
Total Assets (Quarterly) Range, Past 5 Years
29.10M
Minimum
Dec 2019
114.39M
Maximum
Jun 2022
64.97M
Average
58.23M
Median
Total Assets (Quarterly) Benchmarks
Cantabio Pharmaceuticals Inc | 0.3259M |
Q BioMed Inc | 3.465M |
Affymax Inc | -- |
Scopus BioPharma Inc | 0.4976M |
Statera BioPharma Inc | 12.75M |
Total Assets (Quarterly) Related Metrics
Total Liabilities (Quarterly) | 82.62M |
Shareholders Equity (Quarterly) | -2.828M |